IMN || Oncology

Psoriasis patients post above-average cancer rates

Posted on: 22/08/2014 - 18:55

CHICAGO – Malignancy rates in patients with psoriasis outstrip those in the general population, based on data from a retrospective analysis of commercial claims. Rates for all cancers were similar...

Field of Interest: Dermatology
Type: News Item

Unnecessary cancer screening "substantial" in U.S.

Posted on: 18/08/2014 - 21:00

A substantial proportion of older adults in the United States undergo unnecessary and even harmful screening for colon, prostate, breast, and cervical cancer, contrary to clear guidelines that are...

Field of Interest: Oncology
Type: News Item

Unnecessary cancer screening "substantial" in U.S.

Posted on: 18/08/2014 - 21:00

A substantial proportion of older adults in the United States undergo unnecessary and even harmful screening for colon, prostate, breast, and cervical cancer, contrary to clear guidelines that are...

Field of Interest: Geriatrics
Type: News Item

Unnecessary cancer screening "substantial" in U.S.

Posted on: 18/08/2014 - 21:00

A substantial proportion of older adults in the United States undergo unnecessary and even harmful screening for colon, prostate, breast, and cervical cancer, contrary to clear guidelines that are...

Field of Interest: Gastroentero...
Type: News Item

ASCO and AACR call for stronger e-cigarette regulation

Posted on: 14/08/2014 - 22:05

A Food and Drug Administration proposal to regulate e-cigarettes does not go far enough, the American Society of Clinical Oncology and the American Association for Cancer Research say. The two...

Field of Interest: Oncology
Type: News Item

Benefits outweigh harms of aspirin therapy

Posted on: 12/08/2014 - 17:45

Prophylactic aspirin therapy of at least 5 years’ duration has a favorable benefit-harm profile, primarily because of its effectiveness in preventing colorectal and other cancers, according to a...

Field of Interest: Gastroentero...
Type: News Item

Benefits outweigh harms of aspirin therapy

Posted on: 12/08/2014 - 17:45

Prophylactic aspirin therapy of at least 5 years’ duration has a favorable benefit-harm profile, primarily because of its effectiveness in preventing colorectal and other cancers, according to a...

Field of Interest: Oncology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness